Empresa Kiniksa Pharmaceuticals, Ltd.
Acciones
KNSA
BMG5269C1010
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
17,86 USD | +1,02 % | +5,37 % | +1,82 % |
23/04 | Las pérdidas del 1T de Kiniksa Pharmaceuticals se amplían, los ingresos aumentan | MT |
23/04 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Resumen de negocios
Número de empleados: 297
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutic Medicines
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Bermuda
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 01/07/15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01/07/15 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 01/05/18 |
Chad Morin
CMP | Compliance Officer | - | 01/10/20 |
John Paolini
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/08/16 |
Rachel Frank
IRC | Investor Relations Contact | - | - |
General Counsel | - | 01/08/20 | |
Ross Moat
PRN | Corporate Officer/Principal | 43 | 01/01/19 |
Martina Struck
LAW | General Counsel | - | 01/01/18 |
Melissa Manno
HRO | Human Resources Officer | - | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 01/10/15 |
Barry D. Quart
BRD | Director/Board Member | 67 | 01/10/15 |
Thomas Malley
BRD | Director/Board Member | 55 | 01/12/16 |
Richard Levy
BRD | Director/Board Member | 66 | 04/03/19 |
Kim Popovits
BRD | Director/Board Member | 65 | 01/02/18 |
G. Cole
BRD | Director/Board Member | 68 | 27/07/20 |
Stephen Biggar
BRD | Director/Board Member | 53 | 01/10/15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01/07/15 |
Tracey McCain
BRD | Director/Board Member | 56 | 01/02/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 16 057 618 | 0 | 0 | 54,13 % |
Acción B | 1 | 12 781 964 | 0 | 0 | |
Acción C | 1 | 1 795 158 | 0 | 0 | |
Acción D | 1 | 40 304 438 | 38 395 882 ( 95,26 %) | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,82 % | 1266,97 M | |
-1,51 % | 104 mil M | |
+3,22 % | 97,42 mil M | |
+1,60 % | 22,2 mil M | |
-16,53 % | 21,23 mil M | |
-9,19 % | 18,33 mil M | |
-42,33 % | 16,35 mil M | |
-20,09 % | 15,06 mil M | |
+5,47 % | 13,98 mil M | |
+28,85 % | 11,66 mil M |
- Bolsa de valores
- Acciones
- Acción KNSA
- Empresa Kiniksa Pharmaceuticals, Ltd.